Jounce Therapeutics (JNCE) Competitor Comparison
We are evaluating the key criteria listed to compare Jounce Therapeutics (JNCE) against its competitors in the Biotechnology industry.
Market Capitalization
263 / 368Gross Profits
77 / 278Total Revenue
97 / 300EBITDA
136 / 337Free Cashflow
107 / 352Quick Ratio
113 / 357Earnings per Share
130 / 359Dividend yield
0 / 6Total Cash
165 / 358Performance 3 years
190 / 368Performance 5 years
283 / 368Performance 10 years
242 / 368Linearity 3 years
62 / 368Linearity 5 years
249 / 368Linearity 10 years
183 / 368Total Rank
30 / 368Dividend Rank
175 / 368Valuation Rank
79 / 368Piotroski Rank
81 / 368Muliplier Rank
41 / 368Dividend yield - JNCE ranking 0 / 6
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.